Debbie Winn

Dr. Debbie Winn

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2001 in Journal of Dental Education
Verified
Journal Article
Closed access
PDF file
DWDebbie Winn
Debbie Winn

15 August 2005 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
JIJohn P. A. Ioannidis
John P. A. Ioannidis
JBJonine Bernstein
Jonine Bernstein
PBPaolo Boffetta
Paolo Boffetta
JDJohn Danesh
John Danesh
SDSiobhan Dolan
Siobhan Dolan
MKMuin J Khoury
Muin J Khoury
The task of identifying genetic determinants for complex, multigenetic diseases is hampered by small studies, publication and reporting biases, and lack of common standards worldwide. The authors propose the creation of a network of networks that include groups of investigators collecting data for human genome epidemiology research. Twenty-three networks of investigators addressing specific diseases or research topics and representing several hundreds of teams have already joined this initiative. For each field, the authors are currently creating a core registry of teams already participating in the respective network. A wider international registry will include all other teams also working in the same field. Independent investigators are invited to join the registries and existing networks and to join forces in creating additional ones as needed. The network of networks aims to register these networks, teams, and investigators; be a resource for information about or connections to the many networks; offer methodological support; promote sound design and standardization of analytical practices; generate inclusive overviews of fields at large; facilitate rapid confirmation of findings; and avoid duplication of effort.

1 April 2001
Verified
Journal Article
Closed access
DWDebbie Winn
Debbie Winn

2 August 2018 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
MKMuin J Khoury
Muin J Khoury
WFW. Gregory Feero
W. Gregory Feero
DCDavid A. Chambers
David A. Chambers
LBLawrence E. Brody
Lawrence E. Brody
NANazneen Aziz
Nazneen Aziz
GMGeorge A. Mensah
George A. Mensah
In a Policy Forum, Muin Khoury and colleagues discuss research on the clinical application of genome sequencing data.

1 June 2001 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
DWDebbie Winn
Debbie Winn
SDScott R. Diehl
Scott R. Diehl
LBLinda M. Brown
Linda M. Brown
LHLea C. Harty
Lea C. Harty
EBEleuterio Bravo-Otero
Eleuterio Bravo-Otero
RHRichard B. Hayes
Richard B. Hayes

MGMichael Goodman
Michael Goodman
Judy LakindJudy Lakind
Judy Lakind
JFJerald Fagliano
Jerald Fagliano
TLTimothy L. Lash
Timothy L. Lash
JWJoseph L. Wiemels
Joseph L. Wiemels
DMDonald R. Mattison
Donald R. Mattison
Residential clusters of non-communicable diseases are a source of enduring public concern, and at times, controversy. Many clusters reported to public health agencies by concerned citizens are accompanied by expectations that investigations will uncover a cause of disease. While goals, methods and conclusions of cluster studies are debated in the scientific literature and popular press, investigations of reported residential clusters rarely provide definitive answers about disease etiology. Further, it is inherently difficult to study a cluster for diseases with complex etiology and long latency (e.g., most cancers). Regardless, cluster investigations remain an important function of local, state and federal public health agencies. Challenges limiting the ability of cluster investigations to uncover causes for disease include the need to consider long latency, low statistical power of most analyses, uncertain definitions of cluster boundaries and population of interest, and in- and out-migration. A multi-disciplinary Workshop was held to discuss innovative and/or under-explored approaches to investigate cancer clusters. Several potentially fruitful paths forward are described, including modern methods of reconstructing residential history, improved approaches to analyzing spatial data, improved utilization of electronic data sources, advances using biomarkers of carcinogenesis, novel concepts for grouping cases, investigations of infectious etiology of cancer, and “omics” approaches.